CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-11 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −100 | $47.65 | $5K | 85,942 |
| 2024-12-11 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 703,587 | ||
| 2024-12-11 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 701,712 | ||
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +6,579 | $2.90 | $19K | 92,521 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −6,579 | $47.05 | $310K | 85,942 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +7,665 | $2.90 | $22K | 93,607 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −7,665 | $48.18 | $369K | 85,942 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,381 | $2.90 | $4K | 87,323 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,381 | $48.80 | $67K | 85,942 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,875 | $2.90 | $5K | 87,817 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,875 | $48.76 | $91K | 85,942 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +1,875 | $2.90 | $5K | 87,817 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −1,875 | $49.00 | $92K | 85,942 |
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 722,962 | ||
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 721,087 | ||
| 2024-11-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 719,212 | ||
| 2024-11-18 | Carter Jason S Chief Legal Officer | Grant or award | +53,000 | 53,000 | ||
| 2024-11-18 | Carter Jason S Chief Legal Officer | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +12,218 | $2.90 | $35K | 98,160 |
| 2024-11-13 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −12,218 | $49.54 | $605K | 85,942 |
Page 8 of 17 · 321 trades